Diaceutics (DXRX) Competitors GBX 143.80 +0.80 (+0.56%) As of 12:32 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock DXRX vs. YGEN, AGL, ABDX, PRM, VRCI, GENI, GDR, IDHC, DMTR, and LLAIShould you be buying Diaceutics stock or one of its competitors? The main competitors of Diaceutics include Yourgene Health (YGEN), ANGLE (AGL), Abingdon Health (ABDX), Proteome Sciences (PRM), Verici Dx (VRCI), GENinCode (GENI), genedrive (GDR), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), and LungLife AI (LLAI). These companies are all part of the "diagnostics & research" industry. Diaceutics vs. Its Competitors Yourgene Health ANGLE Abingdon Health Proteome Sciences Verici Dx GENinCode genedrive Integrated Diagnostics Deepmatter Group LungLife AI Yourgene Health (LON:YGEN) and Diaceutics (LON:DXRX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations. Does the media prefer YGEN or DXRX? In the previous week, Yourgene Health's average media sentiment score of 0.00 equaled Diaceutics'average media sentiment score. Company Overall Sentiment Yourgene Health Neutral Diaceutics Neutral Do institutionals and insiders have more ownership in YGEN or DXRX? 23.3% of Yourgene Health shares are owned by institutional investors. Comparatively, 24.7% of Diaceutics shares are owned by institutional investors. 64.4% of Yourgene Health shares are owned by company insiders. Comparatively, 26.3% of Diaceutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has preferable valuation & earnings, YGEN or DXRX? Diaceutics has higher revenue and earnings than Yourgene Health. Diaceutics is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioYourgene Health£29.67M0.00-£8.17M-£0.01N/ADiaceutics£32.16M3.78-£2.84M-£0.02-7,118.81 Which has more volatility and risk, YGEN or DXRX? Yourgene Health has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. Comparatively, Diaceutics has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500. Do analysts recommend YGEN or DXRX? Diaceutics has a consensus target price of GBX 175, indicating a potential upside of 21.70%. Given Diaceutics' stronger consensus rating and higher possible upside, analysts clearly believe Diaceutics is more favorable than Yourgene Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Yourgene Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Diaceutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is YGEN or DXRX more profitable? Diaceutics has a net margin of -10.90% compared to Yourgene Health's net margin of -27.55%. Diaceutics' return on equity of -7.15% beat Yourgene Health's return on equity.Company Net Margins Return on Equity Return on Assets Yourgene Health-27.55% -27.06% -6.71% Diaceutics -10.90%-7.15%-6.06% SummaryDiaceutics beats Yourgene Health on 9 of the 13 factors compared between the two stocks. Get Diaceutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DXRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXRX vs. The Competition Export to ExcelMetricDiaceuticsDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£121.58M£50.85M£5.75B£2.58BDividend YieldN/A3.86%5.72%5.30%P/E Ratio-7,118.811.0174.995,404.14Price / Sales3.78479.60456.1096,701.95Price / Cash3.1211.4225.8127.93Price / Book3.132.5613.258.78Net Income-£2.84M£334.07B£3.29B£5.89B7 Day Performance-1.51%-3.44%0.46%0.56%1 Month Performance3.16%-0.25%4.59%44.71%1 Year Performance13.68%13.11%73.41%174.03% Diaceutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXRXDiaceutics1.4243 of 5 starsGBX 143.80+0.6%GBX 175+21.7%+13.0%£121.58M£32.16M-7,118.81151High Trading VolumeYGENYourgene HealthN/AN/AN/AN/A£16.43M£29.67M-51.50253AGLANGLE1.7718 of 5 starsGBX 3.75-6.7%GBX 40+966.7%-71.5%£12.10M£2.86M-77.80650Earnings ReportGap DownABDXAbingdon HealthN/AGBX 5.64-1.8%N/A-41.8%£10.93M£6.82M-773.1584PRMProteome SciencesN/AGBX 3.21-3.2%N/A+17.9%£9.46M£4.89M-278.70240Gap DownVRCIVerici DxN/AGBX 0.50-4.6%N/A-92.7%£7.58M£3.34M-20.0419Gap DownGENIGENinCodeN/AGBX 1.40-9.7%N/AN/A£4.02M£2.70M-55.342,300Gap UpGDRgenedriveN/AGBX 0.60-17.2%N/A-76.6%£3.75M£676K-27.7843High Trading VolumeIDHCIntegrated DiagnosticsN/AGBX 0.56+5.7%N/A+55.3%£3.26M£5.72B0.316,692DMTRDeepmatter GroupN/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap DownLLAILungLife AIN/AGBX 3.50-17.6%N/A-73.6%£1.16M£33.87K-0.2815Negative NewsGap DownHigh Trading Volume Related Companies and Tools Related Companies Yourgene Health Competitors ANGLE Competitors Abingdon Health Competitors Proteome Sciences Competitors Verici Dx Competitors GENinCode Competitors genedrive Competitors Integrated Diagnostics Competitors Deepmatter Group Competitors LungLife AI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:DXRX) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DXRX Stock Alerts